Latest filing published 13 Mar 2023 for AdaptHealth Corp..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel Bunting: trading record in brief
Daniel Bunting, listed as senior executive, appears in our data through filings on AdaptHealth Corp. shares, published by SEC (Form 4). Between 11 October 2021 and 9 March 2023, the trades on record add up to 10 filings.
The open-market record consists of 1 sale worth €2.4M, with no purchase. Outside the open market, there are 8 share grants and 1 option exercise.
The record was last updated on 13 March 2023 with a share grant in AdaptHealth Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel Bunting
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,952 shares0Common StockSEC:0001104659-23-031874:0
- 507 shares@ US$15.990.2% of flowCommon StockSEC:0001104659-23-028022:0
- 3,990 shares@ US$21.382.6% of flowCommon StockSEC:0001104659-23-010764:0
- 1,043 shares@ US$19.340.6% of flowCommon StockSEC:0001104659-23-001019:0
- 223,628 shares@ US$2.6918.6% of flowCommon StockSEC:0001104659-22-126627:0
- 115,078 shares@ US$21.944978.0% of flowCommon StockSEC:0001104659-22-126627:1
- 4,973 shares0Common StockSEC:0001104659-22-025198:0
- 10,422 shares0Common StockSEC:0001104659-22-011411:0
- 955 shares0Common StockSEC:0001104659-21-125925:0
9 of 9 declarations
